Nexalis Therapeutics Limited has released a press release.
Jun25 Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
In the deck
Story so far
Earlier from Nexalis Therapeutics
- Mar25 Quarterly Activities Report
- Mar25 Appendix 4C Cash Flow Report
- IRX Completes First Drawdown Under Clendon Facility
- IRX-616a Study Order Executed to Commence Phase 1
- Study Order Executed for Phase 2 BTcP Trial
Later from Nexalis Therapeutics
- Jun25 Quarterly Activities Report
- Half Yearly Report and Accounts
- Sep25 Appendix 4C Cash Flow Report
- Sep25 Quarterly Activities Report
- Trading Halt
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics